Repressive effects of Lipopolysaccharide from Fusobacterium nucleatum on epithelial type 2 inflammation in eosinophilic chronic rhinosinusitis [PDF]
Masanori Kidoguchi +3 more
openalex +1 more source
Characterisation of novel <i>Fusobacterium nucleatum</i> bacteriophages and their efficacy in disrupting pathogenic dual-species biofilms. [PDF]
Kabwe M +4 more
europepmc +1 more source
Precision Antimicrobial Therapy Against Fusobacterium nucleatum Using Bioengineered Probiotics Expressing Guided Antimicrobial Peptides (gAMPs). [PDF]
Choudhury A +4 more
europepmc +1 more source
The rise and evolving role of <i>Fusobacterium nucleatum</i> subspecies. [PDF]
Wolf M +7 more
europepmc +1 more source
Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer. [PDF]
Queen J +14 more
europepmc +1 more source
Comparative insights into <i>Fusobacterium nucleatum</i> and <i>Helicobacter pylori</i> in human cancers. [PDF]
Gusmaulemova A +3 more
europepmc +1 more source
Fusobacterium nucleatum plays a pathogenic role in a murine model of irritable bowel syndrome by modulating intestinal purine metabolism and promoting mast cell activation. [PDF]
Hou S +10 more
europepmc +1 more source
Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer. [PDF]
Karta J +32 more
europepmc +1 more source
The physical biogeography of Fusobacterium nucleatum in health and disease
James L. Connolly, Libusha Kelly
openalex +1 more source

